Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK InhibitorsClare F. Malone, Kimberly Stegmaier, Minjee Kim et al.|Cancer Research|2022Cited by 17
Supplementary Table S3 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK InhibitorsClare F. Malone, Kimberly Stegmaier, Minjee Kim et al.|Unknown|2023Cited by 0
Supplemental Figures and Legends from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK InhibitorsClare F. Malone, Kimberly Stegmaier, John M. Hatcher et al.|Unknown|2023Cited by 0
Supplementary Table S1 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK InhibitorsClare F. Malone, Kimberly Stegmaier, Minjee Kim et al.|Unknown|2023Cited by 0
Supplementary Table S2 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK InhibitorsClare F. Malone, Kimberly Stegmaier, Minjee Kim et al.|Unknown|2023Cited by 0